Our team

We believe in three principles of team empowerment – liberation, motivation and dedication. 

The talented and experienced analysts and managers who join us are liberated from some of the constraints that have held them back at other firms. Our approach gives them greater scope to explore and discover investment opportunities, and exposes them to a broad diversity of thought, analysis and style. Antipodes is majority owned by the members of our investment team. They’re motivated by clarity of leadership and a remuneration model that both rewards their success and ensures that they remain in close alignment with the interests of our clients. Their dedication comes not only from personal commitment, but from their sole focus on investing. If you study their biographies below, you’ll notice that we’ve drawn our team from a wide variety of abilities and interests. This is a core element of our strategy. As the name Antipodes suggests, we encourage the creative abrasion of contrary points of view that stimulates fresh and clear insights. The construction of our team is designed to encourage this process of intellectual synergy. It adds breadth to our landscape of opportunity and a more profound understanding of the investments we make.

“The way we’re structured and the way our team are rewarded ensures that our culture is totally dedicated to investing and maintaining a close alignment with our clients’ best interests.”

Andrew Findlay, Managing Director & CEO

Leadership team

We are pragmatic value investors who have developed an eclectic process in building high conviction portfolios of global companies.

Our performance driven investment team excels in finding undervalued stocks and building portfolios with a strong focus on generating attractive risk-adjusted returns.

We act for the benefit of our investors while actively contributing to the development of a stable, sustainable and inclusive global economy.

Coming soon to the ASX: the Antipodes Global SMID Fund will be available as an active ETF on the 10th of November 2025

X